Sulfamethoxazole sodium salt CAS:4563-84-2

Sulfamethoxazole sodium salt, often combined with trimethoprim, is widely utilized in clinical practice to treat bacterial infections such as urinary tract infections, respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted diseases. This combination therapy, known as co-trimoxazole or trimethoprim-sulfamethoxazole (TMP-SMX), targets bacterial strains resistant to single-agent therapy and provides synergistic antibacterial effects. Co-trimoxazole is available in oral formulations like tablets and suspension for convenient administration. The dosage and duration of sulfamethoxazole-trimethoprim therapy depend on the type and severity of the infection, as well as individual patient factors. Following the prescribed regimen diligently is crucial to achieve optimal therapeutic outcomes and prevent the development of antibiotic resistance. Patients should be aware of potential side effects associated with sulfamethoxazole sodium salt-containing medications, including gastrointestinal disturbances, allergic reactions, and rare but serious adverse effects like Stevens-Johnson syndrome. Consultation with healthcare professionals for personalized treatment recommendations, monitoring of adverse reactions, and guidance on managing potential side effects is essential for safe and effective use of sulfamethoxazole sodium salt in bacterial infections.